| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8741530 | Osteoarthritis and Cartilage | 2018 | 43 Pages |
Abstract
Visfatin-mediated increase of matrix mineralization and reduced collagen type I expression could contribute to bone fragility. Visfatin is involved in impaired bone remodeling at the adipose tissue/bone interface through induction of proinflammatory factors and dysregulated MMP/TIMP balance during MSC differentiation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
L. Tsiklauri, J. Werner, M. Kampschulte, K.W. Frommer, L. Berninger, M. Irrgang, K. Glenske, D. Hose, T. El Khassawna, J. Pons-Kühnemann, S. Rehart, S. Wenisch, U. Müller-Ladner, E. Neumann,